In this context, NRF2-mediated elevation of HIF-1α has been linked to increased levels of both NRF2 and HIF-1α in breast and bladder cancers, as well as cisplatin resistance in hepatocarcinoma cells (HCCs)56,57. This evidence concerns the gene HIF1A and urinary bladder cancer.